trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Carcinoma D002277 18 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Brain Neoplasms D001932 15 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Melanoma D008545 69 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Asthma D001249 52 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Stroke D020521 32 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Bianco C et al. Regulation of human Cripto-1 expression by nuclear receptors and DNA promoter methylation in human embryonal and breast cancer cells. 2013 J. Cell. Physiol. pmid:23129342
Carbajal A et al. A novel method for purification of polymerizable tubulin with a high content of the acetylated isotype. 2013 Biochem. J. pmid:23140207
Pelascini LP et al. Histone deacetylase inhibition activates transgene expression from integration-defective lentiviral vectors in dividing and non-dividing cells. 2013 Hum. Gene Ther. pmid:23140481
You BR and Park WH Trichostatin A induces apoptotic cell death of HeLa cells in a Bcl-2 and oxidative stress-dependent manner. 2013 Int. J. Oncol. pmid:23165748
Ogura A et al. Recent advancements in cloning by somatic cell nuclear transfer. 2013 Philos. Trans. R. Soc. Lond., B, Biol. Sci. pmid:23166393
Dom G et al. 5-aza-2'-deoxycytidine has minor effects on differentiation in human thyroid cancer cell lines, but modulates genes that are involved in adaptation in vitro. 2013 Thyroid pmid:23167291
Yacqub-Usman K et al. Preincubation of pituitary tumor cells with the epidrugs zebularine and trichostatin A are permissive for retinoic acid-augmented expression of the BMP-4 and D2R genes. 2013 Endocrinology pmid:23539512
Khan DH and Davie JR HDAC inhibitors prevent the induction of the immediate-early gene FOSL1, but do not alter the nucleosome response. 2013 FEBS Lett. pmid:23542037
Chen J et al. Prevention of cytotoxicity of nickel by quercetin: the role of reactive oxygen species and histone acetylation. 2013 Toxicol Ind Health pmid:22294440
Wang F et al. HDAC inhibitor trichostatin A suppresses esophageal squamous cell carcinoma metastasis through HADC2 reduced MMP-2/9. 2013 Clin Invest Med pmid:23544610
Poplineau M et al. Epigenetically induced changes in nuclear textural patterns and gelatinase expression in human fibrosarcoma cells. 2013 Cell Prolif. pmid:23510467
Ding SZ et al. Epithelial-mesenchymal transition during oncogenic transformation induced by hexavalent chromium involves reactive oxygen species-dependent mechanism in lung epithelial cells. 2013 Toxicol. Appl. Pharmacol. pmid:23518002
Azechi T et al. Trichostatin A, an HDAC class I/II inhibitor, promotes Pi-induced vascular calcification via up-regulation of the expression of alkaline phosphatase. 2013 J. Atheroscler. Thromb. pmid:23518467
Zhao TC et al. HDAC inhibition elicits myocardial protective effect through modulation of MKK3/Akt-1. 2013 PLoS ONE pmid:23762381
Saha A et al. Synthesis and biological evaluation of a targeted DNA-binding transcriptional activator with HDAC8 inhibitory activity. 2013 Bioorg. Med. Chem. pmid:23719282
Doherty R et al. Epigenetic regulation of the innate immune response to LPS in bovine peripheral blood mononuclear cells (PBMC). 2013 Vet. Immunol. Immunopathol. pmid:23764468
Liu J et al. Direct differentiation of hepatic stem-like WB cells into insulin-producing cells using small molecules. 2013 Sci Rep pmid:23378917
Shah RR et al. Regulation of primitive hematopoiesis by class I histone deacetylases. 2013 Dev. Dyn. pmid:23184530
Xu M et al. Histone deacetylase inhibitors induce human renal cell carcinoma cell apoptosis through p-JNK activation. 2013 Nan Fang Yi Ke Da Xue Xue Bao pmid:24144737
Peng L et al. [Tricostantin A inhibits self-renewal of breast cancer stem cells in vitro]. 2013 Nan Fang Yi Ke Da Xue Xue Bao pmid:24144739
Chen X et al. The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition of lens epithelial cells. 2013 Cell Death Dis pmid:24157878
Liu YQ et al. Identification of a novel human testicular interstitial gene, RNF148, and its expression regulated by histone deacetylases. 2013 Genet. Mol. Res. pmid:24089095
Florea AM DNA methylation pyrosequencing assay is applicable for the assessment of epigenetic active environmental or clinical relevant chemicals. 2013 Biomed Res Int pmid:24093099
Liu S et al. Up-regulation of miR-182 expression after epigenetic modulation of human melanoma cells. 2013 Ann. Surg. Oncol. pmid:22752337
Jiao F et al. Effect of dynamic DNA methylation and histone acetylation on cPouV expression in differentiation of chick embryonic germ cells. 2013 Stem Cells Dev. pmid:23750509
Tian Y et al. Ubiquitin B in cervical cancer: critical for the maintenance of cancer stem-like cell characters. 2013 PLoS ONE pmid:24367661
Jung AR et al. Increased alternative lengthening of telomere phenotypes of telomerase-negative immortal cells upon trichostatin--a treatment. 2013 Anticancer Res. pmid:23482750
Piazza R et al. Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex. 2013 Neoplasia pmid:23633923
Hu X et al. Histone deacetylase inhibitor trichostatin A promotes the osteogenic differentiation of rat adipose-derived stem cells by altering the epigenetic modifications on Runx2 promoter in a BMP signaling-dependent manner. 2013 Stem Cells Dev. pmid:22873791
Sachweh MC et al. Incompatible effects of p53 and HDAC inhibition on p21 expression and cell cycle progression. 2013 Cell Death Dis pmid:23470540
Hudson RS et al. Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 2013 Mol. Cancer pmid:23409773
Camolotto SA et al. PSG gene expression is up-regulated by lysine acetylation involving histone and nonhistone proteins. 2013 PLoS ONE pmid:23418492
Zutz C et al. Small chemical chromatin effectors alter secondary metabolite production in Aspergillus clavatus. 2013 Toxins (Basel) pmid:24105402
Kim TW et al. Nuclear-encoded mitochondrial MTO1 and MRPL41 are regulated in an opposite epigenetic mode based on estrogen receptor status in breast cancer. 2013 BMC Cancer pmid:24160266
Moreaux J et al. Gene expression-based prediction of myeloma cell sensitivity to histone deacetylase inhibitors. 2013 Br. J. Cancer pmid:23868005
Neumann F et al. EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors. 2013 Cancer Immunol. Immunother. pmid:23619976
Yang H et al. Induction of the liver cancer-down-regulated long noncoding RNA uc002mbe.2 mediates trichostatin-induced apoptosis of liver cancer cells. 2013 Biochem. Pharmacol. pmid:23643933
Majumder A et al. Inhibition of DNA methyltransferases and histone deacetylases induces astrocytic differentiation of neural progenitors. 2013 Stem Cell Res pmid:23644509
Arbuckle JH et al. Mapping the telomere integrated genome of human herpesvirus 6A and 6B. 2013 Virology pmid:23648233
Di Micco S et al. Structural basis for the design and synthesis of selective HDAC inhibitors. 2013 Bioorg. Med. Chem. pmid:23693069
Xia X et al. Effects of trichostatin A in a rat model of acute graft-versus-host disease after liver transplantation. 2013 Transplantation pmid:23694951
Fan J et al. Inhibition of HDAC2 protects the retina from ischemic injury. 2013 Invest. Ophthalmol. Vis. Sci. pmid:23696608
Li M et al. Upregulation of Toll-like receptor 2 gene expression by acetylation of AP-2 alpha in THP-1 cells, a human monocytic cell line. 2013 Int. J. Biochem. Cell Biol. pmid:23680675
Koch M et al. Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: molecular mechanisms unveiled by gene expression profiling. 2013 Biochem. Pharmacol. pmid:23396090
Iwashita J et al. Histone deacetylase induces accelerated maturation in Xenopus laevis oocytes. 2013 Dev. Growth Differ. pmid:23346879
Ji Q et al. Improvement of porcine cloning efficiency by trichostain A through early-stage induction of embryo apoptosis. 2013 Theriogenology pmid:23347745
Theisen JW et al. Biochemical analysis of histone deacetylase-independent transcriptional repression by MeCP2. 2013 J. Biol. Chem. pmid:23349465
Nunes MJ et al. Histone deacetylase inhibition decreases cholesterol levels in neuronal cells by modulating key genes in cholesterol synthesis, uptake and efflux. 2013 PLoS ONE pmid:23326422
Murko C et al. Histone deacetylase inhibitor Trichostatin A induces neural tube defects and promotes neural crest specification in the chicken neural tube. 2013 Differentiation pmid:23328540
Algamas-Dimantov A et al. Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy. 2013 Cell Oncol (Dordr) pmid:23307400